Methods for reducing the incidence of necrotizing enterocolitis
US6306908A · kind A · utility
74Cited by
9References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 12, 2000 |
| Grant date | Oct 23, 2001 |
| Priority date | — |
| Expiry date | May 12, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Enteral formulas that contain long-chain polyunsaturated fatty acids (PUFAs), e.g., arachidonic acid (AA), and docosahexaenoic acid (DHA), essentially free of cholesterol, are described for use in methods for reducing the incidence of necrotizing enterocolitis. Compositions from egg yolk lipids are preferred as they contain .omega.-6 and .omega.-3 long chain PUFAs and are predominantly in a phosphtidylcholine form. This is believed to provide a synergetic effect.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.